HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carboplatin-loaded SMNDs to reduce GSH-mediated platinum resistance for prostate cancer therapy.

Abstract
Glutathione (GSH)-mediated drug resistance can strongly weaken the therapeutic efficiency of platinum(ii). Therapeutic platforms developed based on small-molecule-based nanodrugs (SMNDs) have gained great attention due to their unique properties. Herein, a novel SMND of carboplatin-lauric acid nanoparticles (CBP-LA NPs) was developed for the first time to reduce GSH-mediated platinum resistance and improve the antitumor efficiency of platinum(ii). A CBP-LA conjugate was synthesized and CBP-LA NPs were prepared. Intracellular glutathione determination and intracellular Pt-DNA adduct assay were performed. Then the cellular cytotoxicity, cellular uptake, targeted biodistribution and in vivo antitumor efficacy of CBP-LA NPs were investigated. The CBP-LA conjugate could self-assemble into nanoparticles with small, uniform size and high drug loading (48%). The CBP-LA NPs exhibited a low critical aggregation concentration of 1.4 μg mL-1 and outstanding plasma stability in vitro. Under reduced conditions, the CBP-LA NPs showed redox-responsive behavior. The intracellular glutathione determination and the Pt-DNA adduct assay revealed that CBP-LA NPs could reduce the intracellular GSH levels and improve the efficiency of platinum chelating with DNA, which would overcome GSH-mediated platinum(ii) resistance. The cellular uptake study revealed that CBP-LA NPs were internalized by tumor cells, which was very beneficial for improving the therapeutic efficiency. Furthermore, an in vivo study demonstrated that CBP-LA NPs significantly enhanced drug accumulation at tumor sites and improved antitumor efficiency (p < 0.05) compared to the CBP solution group. This study suggests that CBP-LA NPs are a potential formulation to enhance prostate cancer therapy.
AuthorsShuang Liang , Leiqiang Han , Weiwei Mu , Dandan Jiang , Teng Hou , Xiaolan Yin , Xiuping Pang , Rui Yang , Yongjun Liu , Na Zhang
JournalJournal of materials chemistry. B (J Mater Chem B) Vol. 6 Issue 43 Pg. 7004-7014 (Nov 21 2018) ISSN: 2050-7518 [Electronic] England
PMID32254583 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: